{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:46:44Z","timestamp":1791578804822,"version":"4.3.4"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"name":"The Metro North collaborative research grant scheme","award":["CRG-324-2021"],"award-info":[{"award-number":["CRG-324-2021"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 2002576"],"award-info":[{"award-number":["APP 2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CT chest scans are commonly performed worldwide, either in routine clinical practice for a wide range of indications\u00a0or as part of lung cancer screening programs. Many of these scans detect lung nodules, which are small, rounded opacities measuring 8\u201330\u00a0mm. While the concern about nodules is that they may represent early lung cancer, in screening programs, only 1% of such nodules turn out to be cancer. This leads to a series of complex decisions and, at times, unnecessary biopsies for nodules that are ultimately determined to be benign. Additionally, patients may be anxious about the status of detected lung nodules. The high rate of false positive lung nodule detections has driven advancements in biomarker-based research aimed at triaging lung nodules (benign versus malignant) to identify truly malignant nodules better. Biomarkers found in biofluids and breath hold promise owing to their minimally invasive sampling methods, ease of use, and cost-effectiveness. Although several biomarkers have demonstrated clinical utility, their sensitivity and specificity are still relatively low. Combining multiple biomarkers could enhance the characterisation of small pulmonary nodules by addressing the limitations of individual biomarkers. This approach may help reduce unnecessary invasive procedures and accelerate diagnosis in the future. This review offers a thorough overview of emerging minimally invasive biomarkers for triaging lung nodules, emphasising key challenges and proposing potential solutions for biomarker-based nodule differentiation. It focuses on diagnosis rather than screening, analysing research published primarily in the past five years with some exceptions. The incorporation of biomarkers into clinical practice will facilitate the early detection of malignant nodules, leading to timely interventions and improved outcomes. Further efforts are needed to increase the cost-effectiveness and practicality of many of these applications in clinical settings. However, the range of technologies is advancing rapidly, and they may soon be implemented in clinics in the near future.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10555-025-10247-5","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:58:12Z","timestamp":1738306692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Minimally invasive biomarkers for triaging lung nodules\u2014challenges and future perspectives"],"prefix":"10.1007","volume":"44","author":[{"given":"Waqar Ahmed","family":"Afridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samandra Hernandez","family":"Picos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Muller","family":"Bark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyelle Assis Ferreira","family":"Stamoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarju","family":"Vasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-8259","authenticated-orcid":false,"given":"Chamindie","family":"Punyadeera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"3","key":"10247_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"4","key":"10247_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","volume":"27","author":"R Sharma","year":"2022","unstructured":"Sharma, R. (2022). Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. International Journal of Clinical Oncology, 27(4), 665\u2013675.","journal-title":"International Journal of Clinical Oncology"},{"key":"10247_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2018.04.118","volume":"226\u2013227","author":"D Shlomi","year":"2018","unstructured":"Shlomi, D., Peled, N., Schwarz, Y. A., Soo Hoo, G. W., Batra, R. K., Fink, G., et al. (2018). Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test. Cancer Genetics, 226\u2013227, 1\u201310. https:\/\/doi.org\/10.1016\/j.cancergen.2018.04.118","journal-title":"Cancer Genetics"},{"issue":"1","key":"10247_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/joim.13480","volume":"292","author":"HL Lancaster","year":"2022","unstructured":"Lancaster, H. L., Heuvelmans, M. A., & Oudkerk, M. (2022). Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research. Journal of Internal Medicine, 292(1), 68\u201380. https:\/\/doi.org\/10.1111\/joim.13480","journal-title":"Journal of Internal Medicine"},{"key":"10247_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12880-020-00469-0","volume":"20","author":"S Hadique","year":"2020","unstructured":"Hadique, S., Jain, P., Hadi, Y., Baig, A., & Parker, J. E. (2020). Utility of FDG PET\/CT for assessment of lung nodules identified during low dose computed tomography screening. BMC Medical Imaging, 20, 1\u20136.","journal-title":"BMC Medical Imaging"},{"issue":"10","key":"10247_CR6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2021.1117","volume":"325","author":"AH Krist","year":"2021","unstructured":"Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., et al. (2021). Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA, 325(10), 962\u2013970.","journal-title":"JAMA"},{"issue":"5","key":"10247_CR7","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.21037\/tlcr-20-296","volume":"10","author":"M Silva","year":"2021","unstructured":"Silva, M., Milanese, G., Ledda, R. E., Pastorino, U., & Sverzellati, N. (2021). Screen-detected solid nodules: From detection of nodule to structured reporting. Translational Lung Cancer Research, 10(5), 2335.","journal-title":"Translational Lung Cancer Research"},{"issue":"1","key":"10247_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.21037\/tlcr.2017.01.04","volume":"6","author":"R Wilson","year":"2017","unstructured":"Wilson, R., & Devaraj, A. (2017). Radiomics of pulmonary nodules and lung cancer. Transl Lung Cancer Res, 6(1), 86\u201391. https:\/\/doi.org\/10.21037\/tlcr.2017.01.04","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"10247_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s13665-023-00325-w","volume":"12","author":"A Herring","year":"2023","unstructured":"Herring, A., Chelala, L., & White, C. S. (2023). Lung RADS: Lessons learned and strategies for the optimization of lung cancer screening. Current Pulmonology Reports, 12(4), 181\u2013189.","journal-title":"Current Pulmonology Reports"},{"key":"10247_CR10","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00330-015-3689-0","volume":"25","author":"MM Winkler Wille","year":"2015","unstructured":"Winkler Wille, M. M., van Riel, S. J., Saghir, Z., Dirksen, A., Pedersen, J. H., Jacobs, C., et al. (2015). Predictive accuracy of the PanCan lung cancer risk prediction model-external validation based on CT from the Danish lung cancer screening trial. European Radiology, 25, 3093\u20133099.","journal-title":"European Radiology"},{"key":"10247_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/ccts-20-171","volume":"5","author":"HN Marmor","year":"2021","unstructured":"Marmor, H. N., Zorn, J. T., Deppen, S. A., Massion, P. P., & Grogan, E. L. (2021). Biomarkers in lung cancer screening: A narrative review. Current Challenges in Thoracic Surgery, 5, 5.","journal-title":"Current Challenges in Thoracic Surgery"},{"issue":"10","key":"10247_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.21037\/tlcr-23-291","volume":"12","author":"EK Stephens","year":"2023","unstructured":"Stephens, E. K., Sigcha, J. G., Lopez-Loo, K., Yang, I. A., Marshall, H. M., & Fong, K. M. (2023). Biomarkers of lung cancer for screening and in never-smokers\u2014a narrative review. Translational Lung Cancer Research, 12(10), 2129.","journal-title":"Translational Lung Cancer Research"},{"key":"10247_CR13","doi-asserted-by":"publisher","unstructured":"Mazzone, P. J., Bach, P. B., Carey, J., Schonewolf, C. A., Bognar, K., Ahluwalia, M. S.,\u00a0Cruz-Correa, M., Gierada, D., Kotagiri, S., Lloyd, k., Maldonado, F., Ortendahl, J., Sequist, L., Silvestri, G. A., Tanner, N., Thompson, J. C., Vachani, A., Wong, K. K., Zaidi, A. H... &\u00a0Pike, L. R. G. (2024). Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection. Cancer Discovery, 14(11), 2224\u20132242. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0519","DOI":"10.1158\/2159-8290.CD-24-0519"},{"issue":"5","key":"10247_CR14","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.21037\/jtd-23-250","volume":"15","author":"S Xu","year":"2023","unstructured":"Xu, S., Ge, J., Liu, X., He, Q., Xu, D., Cao, W., et al. (2023). The predictive value of chest computed tomography images, tumor markers, and metabolomics in the identification of benign and malignant pulmonary nodules. Journal of Thoracic Disease, 15(5), 2668.","journal-title":"Journal of Thoracic Disease"},{"issue":"Suppl 7","key":"10247_CR15","doi-asserted-by":"publisher","first-page":"S882","DOI":"10.21037\/jtd.2018.03.81","volume":"10","author":"M Santarpia","year":"2018","unstructured":"Santarpia, M., Liguori, A., D\u2019Aveni, A., Karachaliou, N., Gonzalez-Cao, M., Daffin\u00e0, M. G., et al. (2018). Liquid biopsy for lung cancer early detection. Journal of Thoracic Disease, 10(Suppl 7), S882-s897. https:\/\/doi.org\/10.21037\/jtd.2018.03.81","journal-title":"Journal of Thoracic Disease"},{"issue":"4","key":"10247_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/bios12040223","volume":"12","author":"Q Yu","year":"2022","unstructured":"Yu, Q., Chen, J., Fu, W., Muhammad, K. G., Li, Y., Liu, W., et al. (2022). Smartphone-based platforms for clinical detections in lung-cancer-related exhaled breath biomarkers: A review. Biosensors, 12(4), 223.","journal-title":"Biosensors"},{"issue":"3","key":"10247_CR17","doi-asserted-by":"publisher","first-page":"188729","DOI":"10.1016\/j.bbcan.2022.188729","volume":"1877","author":"L Chang","year":"2022","unstructured":"Chang, L., Li, J., & Zhang, R. (2022). Liquid biopsy for early diagnosis of non-small cell lung carcinoma: Recent research and detection technologies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1877(3), 188729. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188729","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"4","key":"10247_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","volume":"11","author":"C Alix-Panabi\u00e8res","year":"2021","unstructured":"Alix-Panabi\u00e8res, C., & Pantel, K. (2021). Liquid biopsy: From discovery to clinical application. Cancer Discovery, 11(4), 858\u2013873. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1311","journal-title":"Cancer Discovery"},{"issue":"3","key":"10247_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Muller, N. L., & Remy, J. (2008). Fleischner society: Glossary of terms for thoracic imaging. Radiology, 246(3), 697. https:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"issue":"7","key":"10247_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/s1470-2045(16)30069-9","volume":"17","author":"JE Walter","year":"2016","unstructured":"Walter, J. E., Heuvelmans, M. A., de Jong, P. A., Vliegenthart, R., van Ooijen, P. M. A., Peters, R. B., et al. (2016). Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: Analysis of data from the randomised, controlled NELSON trial. The Lancet Oncology, 17(7), 907\u2013916. https:\/\/doi.org\/10.1016\/s1470-2045(16)30069-9","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10247_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/atm.ATM_110_19","volume":"14","author":"K Loverdos","year":"2019","unstructured":"Loverdos, K., Fotiadis, A., Kontogianni, C., Iliopoulou, M., & Gaga, M. (2019). Lung nodules: A comprehensive review on current approach and management. Annals of Thoracic Medicine, 14(4), 226\u2013238. https:\/\/doi.org\/10.4103\/atm.ATM_110_19","journal-title":"Annals of Thoracic Medicine"},{"issue":"9","key":"10247_CR22","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jtho.2018.05.006","volume":"13","author":"JE Walter","year":"2018","unstructured":"Walter, J. E., Heuvelmans, M. A., Yousaf-Khan, U., Dorrius, M. D., Thunnissen, E., Schermann, A., et al. (2018). New subsolid pulmonary nodules in lung cancer screening: The NELSON Trial. Journal of Thoracic Oncology, 13(9), 1410\u20131414. https:\/\/doi.org\/10.1016\/j.jtho.2018.05.006","journal-title":"Journal of Thoracic Oncology"},{"issue":"3","key":"10247_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jama.2021.24287","volume":"327","author":"PJ Mazzone","year":"2022","unstructured":"Mazzone, P. J., & Lam, L. (2022). Evaluating the patient with a pulmonary nodule: A review. JAMA, 327(3), 264\u2013273. https:\/\/doi.org\/10.1001\/jama.2021.24287","journal-title":"JAMA"},{"issue":"1","key":"10247_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1148\/radiol.2261011924","volume":"226","author":"PK Shah","year":"2003","unstructured":"Shah, P. K., Austin, J. H., White, C. S., Patel, P., Haramati, L. B., Pearson, G. D., et al. (2003). Missed non\u2013small cell lung cancer: Radiographic findings of potentially resectable lesions evident only in retrospect. Radiology, 226(1), 235\u2013241.","journal-title":"Radiology"},{"issue":"8","key":"10247_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/thoraxjnl-2017-211376","volume":"73","author":"JE Walter","year":"2018","unstructured":"Walter, J. E., Heuvelmans, M. A., de Bock, G. H., Yousaf-Khan, U., Groen, H. J., van der Aalst, C. M., et al. (2018). Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: The NELSON study. Thorax, 73(8), 741\u2013747. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211376","journal-title":"Thorax"},{"issue":"3","key":"10247_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.rcl.2018.01.002","volume":"56","author":"JB Alpert","year":"2018","unstructured":"Alpert, J. B., & Ko, J. P. (2018). Management of incidental lung nodules: Current strategy and rationale. Radiologic Clinics of North America, 56(3), 339\u2013351. https:\/\/doi.org\/10.1016\/j.rcl.2018.01.002","journal-title":"Radiologic Clinics of North America"},{"issue":"6","key":"10247_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., et al. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England Journal of Medicine, 382(6), 503\u2013513. https:\/\/doi.org\/10.1056\/NEJMoa1911793","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10247_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.21037\/jtd-19-3591","volume":"12","author":"R Zhang","year":"2020","unstructured":"Zhang, R., Tian, P., Qiu, Z., Liang, Y., & Li, W. (2020). The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice. Journal of Thoracic Disease, 12(5), 2019\u20132030. https:\/\/doi.org\/10.21037\/jtd-19-3591","journal-title":"Journal of Thoracic Disease"},{"issue":"4","key":"10247_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmedgenet-2020-107399","volume":"58","author":"MB Lebrett","year":"2021","unstructured":"Lebrett, M. B., Crosbie, E. J., Smith, M. J., Woodward, E. R., Evans, D. G., & Crosbie, P. A. J. (2021). Targeting lung cancer screening to individuals at greatest risk: The role of genetic factors. Journal of Medical Genetics, 58(4), 217\u2013226. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107399","journal-title":"Journal of Medical Genetics"},{"issue":"10","key":"10247_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jama.2021.0377","volume":"325","author":"DE Jonas","year":"2021","unstructured":"Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., et al. (2021). Screening for lung cancer with low-dose computed tomography: Updated evidence report and systematic review for the US preventive services task force. JAMA, 325(10), 971\u2013987. https:\/\/doi.org\/10.1001\/jama.2021.0377","journal-title":"JAMA"},{"issue":"5","key":"10247_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle, D. R., Adams, A. M., Berg, C. D., Black, W. C., Clapp, J. D., Fagerstrom, R. M., et al. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10247_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.21106\/ijma.421","volume":"9","author":"F Bahreini","year":"2020","unstructured":"Bahreini, F., Najafi, R., Amini, R., Khazaei, S., & Bashirian, S. (2020). Reducing false negative PCR test for COVID-19. International Journal of Maternal and Child Health and AIDS, 9(3), 408.","journal-title":"International Journal of Maternal and Child Health and AIDS"},{"issue":"6","key":"10247_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jtho.2021.01.1607","volume":"16","author":"EC Bartlett","year":"2021","unstructured":"Bartlett, E. C., Silva, M., Callister, M. E., & Devaraj, A. (2021). False-negative results in lung cancer screening\u2014evidence and controversies. Journal of Thoracic Oncology, 16(6), 912\u2013921. https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1607","journal-title":"Journal of Thoracic Oncology"},{"issue":"2","key":"10247_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","volume":"174","author":"EF Patz","year":"2014","unstructured":"Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammem\u00e4gi, M. C., et al. (2014). Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Internal Medicine, 174(2), 269\u2013274.","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10247_CR35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2214\/AJR.20.24807","volume":"216","author":"L Chelala","year":"2021","unstructured":"Chelala, L., Hossain, R., Kazerooni, E. A., Christensen, J. D., Dyer, D. S., & White, C. S. (2021). Lung-RADS version 1.1: Challenges and a look ahead, from the AJR special series on radiology reporting and data systems. American Journal of Roentgenology, 216(6), 1411\u20131422.","journal-title":"American Journal of Roentgenology"},{"issue":"10","key":"10247_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJMoa1214726","volume":"369","author":"A McWilliams","year":"2013","unstructured":"McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., et al. (2013). Probability of cancer in pulmonary nodules detected on first screening CT. New England journal of medicine, 369(10), 910\u2013919.","journal-title":"New England journal of medicine"},{"issue":"11","key":"10247_CR37","doi-asserted-by":"publisher","first-page":"e230037","DOI":"10.1148\/rg.230037","volume":"43","author":"MD Martin","year":"2023","unstructured":"Martin, M. D., Kanne, J. P., Broderick, L. S., Kazerooni, E. A., & Meyer, C. A. (2023). RadioGraphics Update: Lung-RADS 2022. Radiographics, 43(11), e230037.","journal-title":"Radiographics"},{"issue":"5","key":"10247_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer, V. A., Force*, U. P. S. T. (2014). Screening for lung cancer: US preventive services task force recommendation statement. Annals of Internal Medicine, 160(5), 330\u2013338.","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10247_CR39","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1016\/j.jacr.2015.12.009","volume":"13","author":"BJ McKee","year":"2016","unstructured":"McKee, B. J., Regis, S. M., McKee, A. B., Flacke, S., & Wald, C. (2016). Performance of ACR Lung-RADS in a clinical CT lung screening program. Journal of the American College of Radiology, 13(2), R25\u2013R29.","journal-title":"Journal of the American College of Radiology"},{"key":"10247_CR40","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1007\/s00330-020-07513-1","volume":"31","author":"H Kim","year":"2021","unstructured":"Kim, H., Kim, H. Y., Goo, J. M., & Kim, Y. (2021). External validation and comparison of the brock model and Lung-RADS for the baseline lung cancer CT screening using data from the Korean lung cancer screening project. European Radiology, 31, 4004\u20134015.","journal-title":"European Radiology"},{"issue":"2","key":"10247_CR41","doi-asserted-by":"publisher","first-page":"e1921221","DOI":"10.1001\/jamanetworkopen.2019.21221","volume":"3","author":"SG Maldonado","year":"2020","unstructured":"Maldonado, S. G., Delorme, S., H\u00fcsing, A., Motsch, E., Kauczor, H.-U., Heussel, C.-P., et al. (2020). Evaluation of prediction models for identifying malignancy in pulmonary nodules detected via low-dose computed tomography. JAMA Network Open, 3(2), e1921221\u2013e1921221.","journal-title":"JAMA Network Open"},{"issue":"3","key":"10247_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacr.2023.09.009","volume":"21","author":"J Christensen","year":"2024","unstructured":"Christensen, J., Prosper, A. E., Wu, C. C., Chung, J., Lee, E., Elicker, B., et al. (2024). ACR lung-RADS v2022: Assessment categories and management recommendations. Journal of the American College of Radiology, 21(3), 473\u2013488.","journal-title":"Journal of the American College of Radiology"},{"issue":"6","key":"10247_CR43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.semnuclmed.2022.05.004","volume":"52","author":"E Novruzov","year":"2022","unstructured":"Novruzov, E., Mori, Y., Antke, C., Dabir, M., Schmitt, D., Kratochwil, C., et al. (2022). A role of non-FDG tracers in lung cancer? Seminars in Nuclear Medicine, 52(6), 720\u2013733. Elsevier.","journal-title":"Seminars in Nuclear Medicine"},{"issue":"6","key":"10247_CR44","first-page":"943","volume":"37","author":"NC Gupta","year":"1996","unstructured":"Gupta, N. C., Maloof, J., & Gunel, E. (1996). Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. Journal of Nuclear Medicine, 37(6), 943\u2013948.","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10247_CR45","doi-asserted-by":"publisher","first-page":"W217","DOI":"10.2214\/AJR.13.11733","volume":"202","author":"AM Maffione","year":"2014","unstructured":"Maffione, A. M., Grassetto, G., Rampin, L., Chondrogiannis, S., Marzola, M. C., Ambrosini, V., et al. (2014). Molecular imaging of pulmonary nodules. American Journal of Roentgenology, 202(3), W217\u2013W223.","journal-title":"American Journal of Roentgenology"},{"issue":"4","key":"10247_CR46","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1378\/chest.128.4.2490","volume":"128","author":"GJ Herder","year":"2005","unstructured":"Herder, G. J., Van Tinteren, H., Golding, R. P., Kostense, P. J., Comans, E. F., Smit, E. F., et al. (2005). Clinical prediction model to characterize pulmonary nodules: Validation and added value of 18 F-fluorodeoxyglucose positron emission tomography. Chest, 128(4), 2490\u20132496.","journal-title":"Chest"},{"issue":"Suppl 2","key":"10247_CR47","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-207168","volume":"70","author":"M Callister","year":"2015","unstructured":"Callister, M., Baldwin, D., Akram, A., Barnard, S., Cane, P., Draffan, J., et al. (2015). British Thoracic Society guidelines for the investigation and management of pulmonary nodules: Accredited by NICE. Thorax, 70(Suppl 2), ii1\u2013ii54.","journal-title":"Thorax"},{"issue":"1","key":"10247_CR48","first-page":"15","volume":"48","author":"IR Yoo","year":"2007","unstructured":"Yoo, I. R., Kim, S. H., Sohn, H. S., & Chung, S. K. (2007). Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET\/CT images of patients with nonthoracic malignancies. Journal of Nuclear Medicine, 48(1), 15\u201321.","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"10247_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.semnuclmed.2020.09.001","volume":"51","author":"MMK Krarup","year":"2021","unstructured":"Krarup, M. M. K., Krokos, G., Subesinghe, M., Nair, A., & Fischer, B. M. (2021). Artificial intelligence for the characterization of pulmonary nodules, lung tumors and mediastinal nodes on PET\/CT. Seminars in Nuclear Medicine, 51(2), 143\u2013156. Elsevier.","journal-title":"Seminars in Nuclear Medicine"},{"issue":"4","key":"10247_CR50","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chest.2021.11.015","volume":"161","author":"PF Pinsky","year":"2022","unstructured":"Pinsky, P. F., Lynch, D. A., & Gierada, D. S. (2022). Incidental findings on low-dose CT scan lung cancer screenings and deaths from respiratory diseases. Chest, 161(4), 1092\u20131100.","journal-title":"Chest"},{"issue":"5","key":"10247_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.molonc.2010.05.002","volume":"4","author":"KD Sutherland","year":"2010","unstructured":"Sutherland, K. D., & Berns, A. (2010). Cell of origin of lung cancer. Molecular Oncology, 4(5), 397\u2013403.","journal-title":"Molecular Oncology"},{"issue":"9","key":"10247_CR52","doi-asserted-by":"publisher","first-page":"e23912","DOI":"10.1002\/jcla.23912","volume":"35","author":"L Xu","year":"2021","unstructured":"Xu, L., Su, Z., & Xie, B. (2021). Diagnostic value of conventional tumor markers in young patients with pulmonary nodules. Journal of Clinical Laboratory Analysis, 35(9), e23912.","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"4","key":"10247_CR53","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.21037\/tcr-21-527","volume":"10","author":"J Li","year":"2021","unstructured":"Li, J., Chen, Y., Wang, X., Wang, C., & Xiao, M. (2021). The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer. Translational Cancer Research, 10(4), 1900.","journal-title":"Translational Cancer Research"},{"issue":"3","key":"10247_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0169-5002(99)00084-7","volume":"26","author":"MD Seemann","year":"1999","unstructured":"Seemann, M. D., Beinert, T., F\u00fcrst, H., & Fink, U. (1999). An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21\u20131) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Lung Cancer, 26(3), 149\u2013155.","journal-title":"Lung Cancer"},{"issue":"3","key":"10247_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1724600819868234","volume":"34","author":"L Fu","year":"2019","unstructured":"Fu, L., Wang, R., Yin, L., Shang, X., Zhang, R., & Zhang, P. (2019). CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis. The International Journal of Biological Markers, 34(3), 251\u2013261.","journal-title":"The International Journal of Biological Markers"},{"issue":"Special 3","key":"10247_CR56","first-page":"C260","volume":"12","author":"H Wang","year":"2016","unstructured":"Wang, H., & Qian, J. (2016). Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis. Journal of Cancer Research and Therapeutics, 12(Special 3), C260\u2013C263.","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"4","key":"10247_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1164\/rccm.201404-0603OC","volume":"193","author":"R Molina","year":"2016","unstructured":"Molina, R., Marrades, R. M., Aug\u00e9, J. M., Escudero, J. M., Vi\u00f1olas, N., Reguart, N., et al. (2016). Assessment of a combined panel of six serum tumor markers for lung cancer. American Journal of Respiratory and Critical Care Medicine, 193(4), 427\u2013437.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10247_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ila2.23","volume":"1","author":"Y Yang","year":"2023","unstructured":"Yang, Y., Chang, S., Wang, N., Song, P., Wei, H., & Liu, J. (2023). Clinical utility of six serum tumor markers for the diagnosis of lung cancer. iLABMED, 1(2), 132\u2013141.","journal-title":"iLABMED"},{"issue":"4","key":"10247_CR59","first-page":"e190006","volume":"2","author":"G Chassagnon","year":"2020","unstructured":"Chassagnon, G., Vakalopoulou, M., R\u00e9gent, A., Zacharaki, E. I., Aviram, G., Martin, C., et al. (2020). Deep learning\u2013based approach for automated assessment of interstitial lung disease in systemic sclerosis on CT images. Radiology: Artificial Intelligence, 2(4), e190006.","journal-title":"Radiology: Artificial Intelligence"},{"issue":"1","key":"10247_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.diii.2022.11.007","volume":"104","author":"C de Margerie-Mellon","year":"2023","unstructured":"de Margerie-Mellon, C., & Chassagnon, G. (2023). Artificial intelligence: A critical review of applications for lung nodule and lung cancer. Diagnostic and Interventional Imaging, 104(1), 11\u201317.","journal-title":"Diagnostic and Interventional Imaging"},{"key":"10247_CR61","doi-asserted-by":"publisher","unstructured":"De Luca, G. R., Diciotti, S., & Mascalchi, M. (2024). The pivotal role of baseline LDCT for lung cancer screening in the era of artificial intelligence. Archivos de Bronconeumologia. https:\/\/doi.org\/10.1016\/j.arbres.2024.11.001","DOI":"10.1016\/j.arbres.2024.11.001"},{"issue":"5","key":"10247_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2214\/AJR.22.27487","volume":"219","author":"JA Liu","year":"2022","unstructured":"Liu, J. A., Yang, I. Y., & Tsai, E. B. (2022). Artificial intelligence (AI) for lung nodules, from the AJR special series on AI applications. American Journal of Roentgenology, 219(5), 703\u2013712.","journal-title":"American Journal of Roentgenology"},{"issue":"2","key":"10247_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1759-7714.12931","volume":"10","author":"L Li","year":"2019","unstructured":"Li, L., Liu, Z., Huang, H., Lin, M., & Luo, D. (2019). Evaluating the performance of a deep learning-based computer-aided diagnosis (DL-CAD) system for detecting and characterizing lung nodules: Comparison with the performance of double reading by radiologists. Thoracic cancer, 10(2), 183\u2013192.","journal-title":"Thoracic cancer"},{"issue":"3","key":"10247_CR64","first-page":"235","volume":"41","author":"G Chassagnon","year":"2023","unstructured":"Chassagnon, G., De Margerie-Mellon, C., Vakalopoulou, M., Marini, R., Hoang-Thi, T.-N., Revel, M.-P., et al. (2023). Artificial intelligence in lung cancer: Current applications and perspectives. Japanese Journal of Radiology, 41(3), 235\u2013244.","journal-title":"Japanese Journal of Radiology"},{"key":"10247_CR65","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00330-009-1596-y","volume":"20","author":"JE Roos","year":"2010","unstructured":"Roos, J. E., Paik, D., Olsen, D., Liu, E. G., Chow, L. C., Leung, A. N., et al. (2010). Computer-aided detection (CAD) of lung nodules in CT scans: Radiologist performance and reading time with incremental CAD assistance. European Radiology, 20, 549\u2013557.","journal-title":"European Radiology"},{"key":"10247_CR66","doi-asserted-by":"publisher","first-page":"108774","DOI":"10.1016\/j.ejrad.2019.108774","volume":"123","author":"G Chassagnon","year":"2020","unstructured":"Chassagnon, G., Vakalopoulou, M., Paragios, N., & Revel, M.-P. (2020). Artificial intelligence applications for thoracic imaging. European Journal of Radiology, 123, 108774.","journal-title":"European Journal of Radiology"},{"issue":"1","key":"10247_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1148\/radiol.2016150063","volume":"281","author":"M Liang","year":"2016","unstructured":"Liang, M., Tang, W., Xu, D. M., Jirapatnakul, A. C., Reeves, A. P., Henschke, C. I., et al. (2016). Low-dose CT screening for lung cancer: Computer-aided detection of missed lung cancers. Radiology, 281(1), 279\u2013288.","journal-title":"Radiology"},{"key":"10247_CR68","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00330-019-06344-z","volume":"30","author":"L-L Qi","year":"2020","unstructured":"Qi, L.-L., Wu, B.-T., Tang, W., Zhou, L.-N., Huang, Y., Zhao, S.-J., et al. (2020). Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning\u2013assisted nodule segmentation. European Radiology, 30, 744\u2013755.","journal-title":"European Radiology"},{"issue":"2","key":"10247_CR69","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016). Radiomics: Images are more than pictures, they are data. Radiology, 278(2), 563\u2013577.","journal-title":"Radiology"},{"issue":"5","key":"10247_CR70","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/app10051718","volume":"10","author":"F Bianconi","year":"2020","unstructured":"Bianconi, F., Palumbo, I., Spanu, A., Nuvoli, S., Fravolini, M. L., & Palumbo, B. (2020). PET\/CT radiomics in lung cancer: An overview. Applied Sciences, 10(5), 1718.","journal-title":"Applied Sciences"},{"issue":"1","key":"10247_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","volume":"11","author":"JE Van Timmeren","year":"2020","unstructured":"Van Timmeren, J. E., Cester, D., Tanadini-Lang, S., Alkadhi, H., & Baessler, B. (2020). Radiomics in medical imaging\u2014\u201chow-to\u201d guide and critical reflection. Insights into Imaging, 11(1), 91.","journal-title":"Insights into Imaging"},{"issue":"2","key":"10247_CR72","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1164\/rccm.201903-0505OC","volume":"202","author":"PP Massion","year":"2020","unstructured":"Massion, P. P., Antic, S., Ather, S., Arteta, C., Brabec, J., Chen, H., et al. (2020). Assessing the accuracy of a deep learning method to risk stratify indeterminate pulmonary nodules. American Journal of Respiratory and Critical Care Medicine, 202(2), 241\u2013249.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10247_CR73","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s10278-020-00372-8","volume":"33","author":"H Liu","year":"2020","unstructured":"Liu, H., Cao, H., Song, E., Ma, G., Xu, X., Jin, R., et al. (2020). Multi-model ensemble learning architecture based on 3D CNN for lung nodule malignancy suspiciousness classification. Journal of Digital Imaging, 33(5), 1242\u20131256. https:\/\/doi.org\/10.1007\/s10278-020-00372-8","journal-title":"Journal of Digital Imaging"},{"issue":"1","key":"10247_CR74","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1038\/s41598-022-08890-x","volume":"12","author":"J Li","year":"2022","unstructured":"Li, J., Li, X., Li, M., Qiu, H., Saad, C., Zhao, B., et al. (2022). Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes. Scientific Reports, 12(1), 5070. https:\/\/doi.org\/10.1038\/s41598-022-08890-x","journal-title":"Scientific Reports"},{"issue":"2","key":"10247_CR75","first-page":"743","volume":"13","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Yang, J., Shen, L., Chen, J., Xia, L., Ni, B., et al. (2021). A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1\/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer. American Journal of Translational Research, 13(2), 743.","journal-title":"American Journal of Translational Research"},{"issue":"4","key":"10247_CR76","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.21037\/qims-21-609","volume":"12","author":"Y Gao","year":"2022","unstructured":"Gao, Y., Hua, M., Lv, J., Ma, Y., Liu, Y., Ren, M., et al. (2022). Reproducibility of radiomic features of pulmonary nodules between low-dose CT and conventional-dose CT. Quantitative Imaging in Medicine and Surgery, 12(4), 2368.","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"10247_CR77","unstructured":"(2024) Apply artificial intelligence to determine the benign or malignancy for pulmonary ground glass nodules of computed tomography. https:\/\/clinicaltrials.gov\/study\/NCT06282068"},{"issue":"4","key":"10247_CR78","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/thoraxjnl-2019-214104","volume":"75","author":"DR Baldwin","year":"2020","unstructured":"Baldwin, D. R., Gustafson, J., Pickup, L., Arteta, C., Novotny, P., Declerck, J., et al. (2020). External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules. Thorax, 75(4), 306\u2013312.","journal-title":"Thorax"},{"key":"10247_CR79","doi-asserted-by":"publisher","unstructured":"Wang, C., Shao, J., He, Y., Wu, J., Liu, X., Yang, L., Wei, Y., Zhou, XS., Zhan, Y., Shi, F., Shen, D., & Li, W. (2024). Data-driven risk stratification and precision management of pulmonary nodules detected on chest computed tomography. Nature Medicine, 30(11), 3184\u20133195. https:\/\/doi.org\/10.1038\/s41591-024-03211-3","DOI":"10.1038\/s41591-024-03211-3"},{"key":"10247_CR80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymeth.2020.05.022","volume":"188","author":"A Ibrahim","year":"2021","unstructured":"Ibrahim, A., Primakov, S., Beuque, M., Woodruff, H., Halilaj, I., Wu, G., et al. (2021). Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework. Methods, 188, 20\u201329.","journal-title":"Methods"},{"issue":"44","key":"10247_CR81","doi-asserted-by":"publisher","first-page":"71223","DOI":"10.18632\/oncotarget.12086","volume":"7","author":"A Kulasinghe","year":"2016","unstructured":"Kulasinghe, A., Kenny, L., Perry, C., Thiery, J.-P., Jovanovic, L., Vela, I., et al. (2016). Impact of label-free technologies in head and neck cancer circulating tumour cells. Oncotarget, 7(44), 71223.","journal-title":"Oncotarget"},{"issue":"2","key":"10247_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1586\/14737159.2016.1127758","volume":"16","author":"H Schmidt","year":"2016","unstructured":"Schmidt, H., Kulasinghe, A., Perry, C., Nelson, C., & Punyadeera, C. (2016). A liquid biopsy for head and neck cancers. Expert Review of Molecular Diagnostics, 16(2), 165\u2013172.","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"10247_CR83","doi-asserted-by":"crossref","unstructured":"Punyadeera, C., & Slowey, P. D. (2019). Saliva as an emerging biofluid for clinical diagnosis and applications of MEMS\/NEMS in salivary diagnostics. In K. Subramani, & W. Ahmed (Eds.), Nanobiomaterials in Clinical Dentistry (4th ed., pp 543\u2013565).\u00a0Elsevier.","DOI":"10.1016\/B978-0-12-815886-9.00022-X"},{"issue":"3","key":"10247_CR84","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jtho.2018.11.023","volume":"14","author":"LM Seijo","year":"2019","unstructured":"Seijo, L. M., Peled, N., Ajona, D., Boeri, M., Field, J. K., Sozzi, G., et al. (2019). Biomarkers in lung cancer screening: Achievements, promises, and challenges. Journal of Thoracic Oncology, 14(3), 343\u2013357.","journal-title":"Journal of Thoracic Oncology"},{"key":"10247_CR85","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.2147\/ott.S203070","volume":"12","author":"Z Wu","year":"2019","unstructured":"Wu, Z., Yang, Z., Dai, Y., Zhu, Q., & Chen, L. A. (2019). Update on liquid biopsy in clinical management of non-small cell lung cancer. OncoTargets and Therapy, 12, 5097\u20135109. https:\/\/doi.org\/10.2147\/ott.S203070","journal-title":"OncoTargets and Therapy"},{"key":"10247_CR86","doi-asserted-by":"publisher","unstructured":"Afridi, W. A., Strachan, S., Kasetsirikul, S., Pannu, A. S., Soda, N., Gough, D., Nguyen, N. T., & Shiddiky, J. A. (2023). Potential Avenues for Exosomal Isolation and Detection Methods to Enhance Small-Cell Lung Cancer Analysis. ACS Measurement Science Au, 3(3), 143-161. https:\/\/doi.org\/10.1021\/acsmeasuresciau.2c00068","DOI":"10.1021\/acsmeasuresciau.2c00068"},{"key":"10247_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2020.06.006","volume":"101","author":"JM Bark","year":"2021","unstructured":"Bark, J. M., Kulasinghe, A., Amenabar, J. M., & Punyadeera, C. (2021). Exosomes in cancer. Advances in Clinical Chemistry, 101, 1\u201340.","journal-title":"Advances in Clinical Chemistry"},{"issue":"4","key":"10247_CR88","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40291-021-00538-2","volume":"25","author":"KD Tang","year":"2021","unstructured":"Tang, K. D., Wan, Y., Zhang, X., Bozyk, N., Vasani, S., Kenny, L., et al. (2021). Proteomic alterations in salivary exosomes derived from human papillomavirus-driven oropharyngeal cancer. Molecular Diagnosis & Therapy, 25(4), 505\u2013515.","journal-title":"Molecular Diagnosis & Therapy"},{"issue":"18","key":"10247_CR89","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1002\/cncr.34888","volume":"129","author":"JM Bark","year":"2023","unstructured":"Bark, J. M., de Lima, L. T. F., Zhang, X., Broszczak, D., Leo, P. J., Jeffree, R. L., et al. (2023). Proteome profiling of salivary small extracellular vesicles in glioblastoma patients. Cancer, 129(18), 2836\u20132847.","journal-title":"Cancer"},{"key":"10247_CR90","doi-asserted-by":"publisher","unstructured":"Jangholi, A., Bark, J. M., de Lima, L. T. F., Lima, L. G., M\u00f6ller, A., Kenny, L., Vasani, S., Rao, S., Dolcetti, R., & Punyadeera, C. (2023). Method optimisation to enrich small extracellular vesicles from saliva samples. Clinical and Translational Medicine, 13(8), e1341.  https:\/\/doi.org\/10.1002\/ctm2.1341","DOI":"10.1002\/ctm2.1341"},{"issue":"8","key":"10247_CR91","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.7150\/thno.41580","volume":"10","author":"D Yang","year":"2020","unstructured":"Yang, D., Zhang, W., Zhang, H., Zhang, F., Chen, L., Ma, L., et al. (2020). Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics, 10(8), 3684.","journal-title":"Theranostics"},{"issue":"1","key":"10247_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0753-1","volume":"19","author":"N Zhang","year":"2020","unstructured":"Zhang, N., Nan, A., Chen, L., Li, X., Jia, Y., Qiu, M., Dai, X., Zhou, H., Zhu, J., Zhang, H., & Jiang, Y. (2020). Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. Molecular Cancer, 19(1), 1\u201316.","journal-title":"Molecular Cancer"},{"issue":"1","key":"10247_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12014-019-9225-5","volume":"16","author":"M Kuang","year":"2019","unstructured":"Kuang, M., Tao, X., Peng, Y., Zhang, W., Pan, Y., Cheng, L., et al. (2019). Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules. Clinical Proteomics, 16(1), 1\u201311.","journal-title":"Clinical Proteomics"},{"key":"10247_CR94","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10238-019-00581-8","volume":"19","author":"M Kuang","year":"2019","unstructured":"Kuang, M., Peng, Y., Tao, X., Zhou, Z., Mao, H., Zhuge, L., et al. (2019). FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules. Clinical and Experimental Medicine, 19, 557\u2013564.","journal-title":"Clinical and Experimental Medicine"},{"key":"10247_CR95","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fgene.2019.00496","volume":"10","author":"J Li","year":"2019","unstructured":"Li, J., & Liu, C. (2019). Coding or noncoding, the converging concepts of RNAs. Frontiers in Genetics, 10, 496.","journal-title":"Frontiers in Genetics"},{"issue":"7","key":"10247_CR96","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/14737159.2017.1339603","volume":"17","author":"S Satapathy","year":"2017","unstructured":"Satapathy, S., Batra, J., Jeet, V., Thompson, E. W., & Punyadeera, C. (2017). MicroRNAs in HPV associated cancers: Small players with big consequences. Expert Review of Molecular Diagnostics, 17(7), 711\u2013722.","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"10247_CR97","doi-asserted-by":"publisher","unstructured":"Arunachalam, S. R., Tang, K. D., & Punyadeera, C. (2019). Isolation and quantification of MicroRNAs from human saliva. Isolation and Quantification of MicroRNAs from Human Saliva. In: Batra, J., Srinivasan, S. (eds) Theranostics. Methods in Molecular Biology, vol 2054. Humana, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-9769-5_6","DOI":"10.1007\/978-1-4939-9769-5_6"},{"key":"10247_CR98","doi-asserted-by":"publisher","unstructured":"Ekanayake Weeramange, C., Tang, K. D., Barrero, R. A., Hartel, G., Liu, Z., Ladwa, R.,\u00a0Langton-Lockton, J., Frazer, I., Kenny, L., Vasani, S., & Punyadeera, C.\u00a0(2023). Salivary micro RNAs as biomarkers for oropharyngeal cancer. Cancer Medicine, 12(14), 15128\u201315140. https:\/\/doi.org\/10.1002\/cam4.6185","DOI":"10.1002\/cam4.6185"},{"issue":"3","key":"10247_CR99","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1002\/wrna.1754","volume":"14","author":"J Balakittnen","year":"2023","unstructured":"Balakittnen, J., Weeramange, C. E., Wallace, D. F., Duijf, P. H., Cristino, A. S., Kenny, L., et al. (2023). Noncoding RNAs in oral cancer. Wiley Interdisciplinary Reviews: RNA, 14(3), e1754.","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"key":"10247_CR100","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2020.12.040","volume":"502","author":"S Tang","year":"2021","unstructured":"Tang, S., Li, S., Liu, T., He, Y., Hu, H., Zhu, Y., et al. (2021). MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer. Cancer Letters, 502, 71\u201383.","journal-title":"Cancer Letters"},{"issue":"9","key":"10247_CR101","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/JTO.0b013e318299ac32","volume":"8","author":"R Cazzoli","year":"2013","unstructured":"Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., et al. (2013). microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. Journal of Thoracic Oncology, 8(9), 1156\u20131162.","journal-title":"Journal of Thoracic Oncology"},{"issue":"8","key":"10247_CR102","first-page":"3185","volume":"33","author":"T Arita","year":"2013","unstructured":"Arita, T., Ichikawa, D., Konishi, H., Komatsu, S., Shiozaki, A., Shoda, K., et al. (2013). Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Research, 33(8), 3185\u20133193.","journal-title":"Anticancer Research"},{"issue":"4","key":"10247_CR103","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1002\/ctm2.367","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Zitello, E., Guo, R., & Deng, Y. (2021). The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clinical and Translational Medicine, 11(4), e367.","journal-title":"Clinical and Translational Medicine"},{"issue":"7","key":"10247_CR104","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41416-020-0742-9","volume":"122","author":"A Acha-Sagredo","year":"2020","unstructured":"Acha-Sagredo, A., Uko, B., Pantazi, P., Bediaga, N. G., Moschandrea, C., Rainbow, L., et al. (2020). Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. British Journal of Cancer, 122(7), 1050\u20131058.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10247_CR105","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/CBM-190161","volume":"26","author":"C Gupta","year":"2019","unstructured":"Gupta, C., Su, J., Zhan, M., Stass, S. A., & Jiang, F. (2019). Sputum long non-coding RNA biomarkers for diagnosis of lung cancer. Cancer Biomarkers, 26(2), 219\u2013227.","journal-title":"Cancer Biomarkers"},{"key":"10247_CR106","doi-asserted-by":"publisher","first-page":"537120","DOI":"10.3389\/fonc.2020.537120","volume":"10","author":"S Yuan","year":"2020","unstructured":"Yuan, S., Xiang, Y., Guo, X., Zhang, Y., Li, C., Xie, W., et al. (2020). Circulating long noncoding RNAs act as diagnostic biomarkers in non-small cell lung cancer. Frontiers in Oncology, 10, 537120.","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10247_CR107","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/jcb.29475","volume":"121","author":"F Chen","year":"2020","unstructured":"Chen, F., Huang, C., Wu, Q., Jiang, L., Chen, S., & Chen, L. (2020). Circular RNAs expression profiles in plasma exosomes from early-stage lung adenocarcinoma and the potential biomarkers. Journal of Cellular Biochemistry, 121(3), 2525\u20132533.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"10247_CR108","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/17246008211073151","volume":"37","author":"Y Luo","year":"2022","unstructured":"Luo, Y., Zhang, Q., Lv, B., Shang, Y., Li, J., Yang, L., et al. (2022). CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer. The International Journal of Biological Markers, 37(1), 58\u201365.","journal-title":"The International Journal of Biological Markers"},{"issue":"19","key":"10247_CR109","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.3390\/cancers15194774","volume":"15","author":"E Garbo","year":"2023","unstructured":"Garbo, E., Del Rio, B., Ferrari, G., Cani, M., Napoli, V. M., Bertaglia, V., et al. (2023). Exploring the potential of non-coding RNAs as liquid biopsy biomarkers for lung cancer screening: A literature review. Cancers, 15(19), 4774.","journal-title":"Cancers"},{"key":"10247_CR110","doi-asserted-by":"publisher","first-page":"109206","DOI":"10.1016\/j.clim.2022.109206","volume":"246","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Li, J., Zhang, X., Liu, M., Ji, L., Yang, T., et al. (2023). Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer. Clinical Immunology, 246, 109206.","journal-title":"Clinical Immunology"},{"issue":"3","key":"10247_CR111","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtho.2015.11.011","volume":"11","author":"J Wang","year":"2016","unstructured":"Wang, J., Shivakumar, S., Barker, K., Tang, Y., Wallstrom, G., Park, J. G., et al. (2016). Comparative study of autoantibody responses between lung adenocarcinoma and benign pulmonary nodules. Journal of Thoracic Oncology, 11(3), 334\u2013345.","journal-title":"Journal of Thoracic Oncology"},{"issue":"4","key":"10247_CR112","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/COC.0000000000001069","volume":"47","author":"X Liu","year":"2024","unstructured":"Liu, X., Shen, Q., Wen, Y., Jiang, Z., Ma, Z., Zeng, P., et al. (2024). Diagnosis of malignant pulmonary nodules using a combination of tumor-associated autoantibodies and computed tomography. American Journal of Clinical Oncology, 47(4), 149\u2013154.","journal-title":"American Journal of Clinical Oncology"},{"issue":"3","key":"10247_CR113","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jtho.2016.08.143","volume":"12","author":"PP Massion","year":"2017","unstructured":"Massion, P. P., Healey, G. F., Peek, L. J., Fredericks, L., Sewell, H. F., Murray, A., et al. (2017). Autoantibody signature enhances the positive predictive power of computed tomography and nodule-based risk models for detection of lung cancer. Journal of Thoracic Oncology, 12(3), 578\u2013584.","journal-title":"Journal of Thoracic Oncology"},{"key":"10247_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-018-1376-2","volume":"14","author":"S Bamji-Stocke","year":"2018","unstructured":"Bamji-Stocke, S., van Berkel, V., Miller, D. M., & Frieboes, H. B. (2018). A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment. Metabolomics, 14, 1\u201316.","journal-title":"Metabolomics"},{"issue":"6","key":"10247_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2023.13851","volume":"25","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Dong, X., Qin, C., Wang, F., Cao, W., Li, J., et al. (2023). Metabolic biomarkers in lung cancer screening and early diagnosis. Oncology Letters, 25(6), 1\u201311.","journal-title":"Oncology Letters"},{"issue":"1","key":"10247_CR116","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1038\/s41467-020-17347-6","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang, L., Wang, L., Hu, X., Chen, S., Tao, Y., Su, H., et al. (2020). Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nature Communications, 11(1), 3556.","journal-title":"Nature Communications"},{"issue":"8","key":"10247_CR117","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/metabo11080537","volume":"11","author":"E Derveaux","year":"2021","unstructured":"Derveaux, E., Thomeer, M., Mesotten, L., Reekmans, G., & Adriaensens, P. (2021). Detection of lung cancer via blood plasma and 1H-NMR metabolomics: Validation by a semi-targeted and quantitative approach using a protein-binding competitor. Metabolites, 11(8), 537.","journal-title":"Metabolites"},{"issue":"9","key":"10247_CR118","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1021\/pr200550p","volume":"10","author":"CM Rocha","year":"2011","unstructured":"Rocha, C. M., Carrola, J., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., et al. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. Journal of Proteome Research, 10(9), 4314\u20134324.","journal-title":"Journal of Proteome Research"},{"issue":"11","key":"10247_CR119","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.18632\/oncotarget.7354","volume":"7","author":"L Puchades-Carrasco","year":"2016","unstructured":"Puchades-Carrasco, L., Jantus-Lewintre, E., P\u00e9rez-Rambla, C., Garc\u00eda-Garc\u00eda, F., Lucas, R., Calabuig, S., et al. (2016). Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Oncotarget, 7(11), 12904.","journal-title":"Oncotarget"},{"issue":"1","key":"10247_CR120","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/pr9006574","volume":"9","author":"CM Rocha","year":"2010","unstructured":"Rocha, C. M., Barros, A. S., Gil, A. M., Goodfellow, B. J., Humpfer, E., Spraul, M., et al. (2010). Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. Journal of Proteome Research, 9(1), 319\u2013332.","journal-title":"Journal of Proteome Research"},{"key":"10247_CR121","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00432-017-2347-0","volume":"143","author":"A Klupczynska","year":"2017","unstructured":"Klupczynska, A., Derezi\u0144ski, P., Garrett, T. J., Rubio, V. Y., Dyszkiewicz, W., Kasprzyk, M., et al. (2017). Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics. Journal of Cancer Research and Clinical Oncology, 143, 649\u2013659.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"64","key":"10247_CR122","doi-asserted-by":"publisher","first-page":"107899","DOI":"10.18632\/oncotarget.22391","volume":"8","author":"Z Yu","year":"2017","unstructured":"Yu, Z., Chen, H., Ai, J., Zhu, Y., Li, Y., Borgia, J. A., et al. (2017). Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer. Oncotarget, 8(64), 107899.","journal-title":"Oncotarget"},{"issue":"1","key":"10247_CR123","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12929-023-00953-z","volume":"30","author":"X Huang","year":"2023","unstructured":"Huang, X., Duijf, P. H., Sriram, S., Perera, G., Vasani, S., Kenny, L., et al. (2023). Circulating tumour DNA alterations: Emerging biomarker in head and neck squamous cell carcinoma. Journal of Biomedical Science, 30(1), 65.","journal-title":"Journal of Biomedical Science"},{"key":"10247_CR124","doi-asserted-by":"publisher","unstructured":"Huang, X., Leo, P., Jones, L., Duijf, P. H. G, Hartel, G., Kenny, L., Vasani, S., & Punyadeera, C (2023). A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma---A systematic review. Mutation Research\/Reviews in Mutation Research, 793, 108477. https:\/\/doi.org\/10.1016\/j.mrrev.2023.108477","DOI":"10.1016\/j.mrrev.2023.108477"},{"issue":"9","key":"10247_CR125","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey, A., Church, M., Rothwell, D., Dive, C., & Cook, N. (2022). Circulating tumour DNA \u2014 looking beyond the blood. Nature Reviews Clinical Oncology, 19(9), 600\u2013612. https:\/\/doi.org\/10.1038\/s41571-022-00660-y","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10247_CR126","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrep.2018.06.002","volume":"15","author":"SE-S Soliman","year":"2018","unstructured":"Soliman, S.E.-S., Alhanafy, A. M., Habib, M. S. E. D., Hagag, M., & Ibrahem, R. A. L. (2018). Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer. Biochemistry and Biophysics Reports, 15, 45\u201351.","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"2","key":"10247_CR127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ab.2012.06.018","volume":"433","author":"L Benesova","year":"2013","unstructured":"Benesova, L., Belsanova, B., Suchanek, S., Kopeckova, M., Minarikova, P., Lipska, L., et al. (2013). Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Analytical Biochemistry, 433(2), 227\u2013234.","journal-title":"Analytical Biochemistry"},{"issue":"3","key":"10247_CR128","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/bjc.2015.225","volume":"113","author":"A Szpechcinski","year":"2015","unstructured":"Szpechcinski, A., Chorostowska-Wynimko, J., Struniawski, R., Kupis, W., Rudzinski, P., Langfort, R., et al. (2015). Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease. British Journal of Cancer, 113(3), 476\u2013483. https:\/\/doi.org\/10.1038\/bjc.2015.225","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10247_CR129","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/s41598-021-85797-z","volume":"11","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Li, C., Zhang, Z., Li, D. Y., Du, J., Ding, P., et al. (2021). Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients. Scientific Reports, 11(1), 7633.","journal-title":"Scientific Reports"},{"issue":"11","key":"10247_CR130","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/cells9112486","volume":"9","author":"L Durin","year":"2020","unstructured":"Durin, L., Pradines, A., Basset, C., Ulrich, B., Keller, L., Dongay, V., et al. (2020). Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: Look closer to the tumor! Cells, 9(11), 2486.","journal-title":"Cells"},{"issue":"13","key":"10247_CR131","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.21037\/atm-21-2579","volume":"9","author":"D Zeng","year":"2021","unstructured":"Zeng, D., Wang, C., Mu, C., Su, M., Mao, J., Huang, J., et al. (2021). Cell-free DNA from bronchoalveolar lavage fluid (BALF): A new liquid biopsy medium for identifying lung cancer. Annals of Translational Medicine, 9(13), 1080.","journal-title":"Annals of Translational Medicine"},{"issue":"7761","key":"10247_CR132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","volume":"570","author":"S Cristiano","year":"2019","unstructured":"Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., et al. (2019). Genome-wide cell-free DNA fragmentation in patients with cancer. Nature, 570(7761), 385\u2013389.","journal-title":"Nature"},{"issue":"1","key":"10247_CR133","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","volume":"12","author":"D Mathios","year":"2021","unstructured":"Mathios, D., Johansen, J. S., Cristiano, S., Medina, J. E., Phallen, J., Larsen, K. R., et al. (2021). Detection and characterization of lung cancer using cell-free DNA fragmentomes. Nature Communications, 12(1), 5060.","journal-title":"Nature Communications"},{"key":"10247_CR134","unstructured":"(2021). DNA evaluation of fragments for early interception - lung cancer training study (DELFI-L101 Study). https:\/\/clinicaltrials.gov\/study\/NCT04825834"},{"issue":"11","key":"10247_CR135","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1158\/2159-8290.CD-24-0519","volume":"14","author":"PJ Mazzone","year":"2024","unstructured":"Mazzone, P. J., Bach, P. B., Carey, J., Schonewolf, C. A., Bognar, K., Ahluwalia, M. S., et al. (2024). Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection. Cancer Discovery, 14(11), 2224\u20132242.","journal-title":"Cancer Discovery"},{"issue":"16","key":"10247_CR136","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.3390\/jcm13164911","volume":"13","author":"LB Cotton","year":"2024","unstructured":"Cotton, L. B., Bach, P. B., Cisar, C., Schonewolf, C. A., Tennefoss, D., Vachani, A., et al. (2024). Innovations in early lung cancer detection: Tracing the evolution and advancements in screening. Journal of Clinical Medicine, 13(16), 4911.","journal-title":"Journal of Clinical Medicine"},{"key":"10247_CR137","doi-asserted-by":"publisher","first-page":"8107318","DOI":"10.1155\/2019\/8107318","volume":"2019","author":"Y-X Shi","year":"2019","unstructured":"Shi, Y.-X., Sheng, D.-Q., Cheng, L., & Song, X.-Y. (2019). Current landscape of epigenetics in lung cancer: Focus on the mechanism and application. Journal of Oncology, 2019, 8107318. https:\/\/doi.org\/10.1155\/2019\/8107318","journal-title":"Journal of Oncology"},{"key":"10247_CR138","doi-asserted-by":"publisher","first-page":"BMI-S16199","DOI":"10.4137\/BMI.S16199","volume":"9","author":"DA Ovchinnikov","year":"2014","unstructured":"Ovchinnikov, D. A., Wan, Y., Coman, W. B., Pandit, P., Cooper-White, J. J., Herman, J. G., et al. (2014). DNA methylation at the novel CpG sites in the promoter of MED15\/PCQAP gene as a biomarker for head and neck cancers. Biomarker Insights, 9, BMI-S16199.","journal-title":"Biomarker Insights"},{"key":"10247_CR139","doi-asserted-by":"publisher","unstructured":"Hoang, P. H., & Landi, M. T. (2022). DNA methylation in lung cancer: Mechanisms and Associations with histological subtypes, molecular alterations, and major epidemiological factors. Cancers, 14(4), https:\/\/doi.org\/10.3390\/cancers14040961","DOI":"10.3390\/cancers14040961"},{"issue":"1","key":"10247_CR140","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41467-019-09301-y","volume":"10","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y., Amador, C., Xia, C., Marioni, R., Sproul, D., Walker, R. M., et al. (2019). Parent of origin genetic effects on methylation in humans are common and influence complex trait variation. Nature Communications, 10(1), 1383. https:\/\/doi.org\/10.1038\/s41467-019-09301-y","journal-title":"Nature Communications"},{"issue":"4","key":"10247_CR141","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4103\/jcrt.JCRT_790_18","volume":"15","author":"J Zhao","year":"2019","unstructured":"Zhao, J., Cui, X., Huang, X., Lu, R., Chen, P., & Zhang, Z. (2019). Methylation of RUNX3 and RASSF1A and the risk of Malignancy in small solitary pulmonary nodules. Journal of Cancer Research and Therapeutics, 15(4), 899\u2013903. https:\/\/doi.org\/10.4103\/jcrt.JCRT_790_18","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"9","key":"10247_CR142","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1111\/cas.15052","volume":"112","author":"J Qi","year":"2021","unstructured":"Qi, J., Hong, B., Tao, R., Sun, R., Zhang, H., Zhang, X., et al. (2021). Prediction model for malignant pulmonary nodules based on cfMeDIP-seq and machine learning. Cancer Science, 112(9), 3918\u20133923. https:\/\/doi.org\/10.1111\/cas.15052","journal-title":"Cancer Science"},{"key":"10247_CR143","doi-asserted-by":"publisher","unstructured":"Liang, W., Chen, Z., Li, C., Liu, J., Tao, J., Liu, X. et al. (2021). Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. The Journal of Clinical Investigation, 131(10), https:\/\/doi.org\/10.1172\/JCI145973","DOI":"10.1172\/JCI145973"},{"issue":"10, Supplement","key":"10247_CR144","doi-asserted-by":"publisher","first-page":"S877","DOI":"10.1016\/j.jtho.2021.08.089","volume":"16","author":"W Liang","year":"2021","unstructured":"Liang, W., Liu, Q., Wang, B., Tao, J., Chen, Z., Zeng, Q., et al. (2021). OA16.04 a combined model of clinical, imaging and DNA methylation biomarkers to improve the classification of pulmonary nodules. Journal of Thoracic Oncology, 16(10, Supplement), S877. https:\/\/doi.org\/10.1016\/j.jtho.2021.08.089","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"10247_CR145","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13148-021-01163-w","volume":"13","author":"L Li","year":"2021","unstructured":"Li, L., Ye, Z., Yang, S., Yang, H., Jin, J., Zhu, Y., et al. (2021). Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids. Clinical Epigenetics, 13(1), 185. https:\/\/doi.org\/10.1186\/s13148-021-01163-w","journal-title":"Clinical Epigenetics"},{"issue":"8","key":"10247_CR146","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/1078-0432.Ccr-16-1371","volume":"23","author":"A Hulbert","year":"2017","unstructured":"Hulbert, A., Jusue-Torres, I., Stark, A., Chen, C., Rodgers, K., Lee, B., et al. (2017). Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum. Clinical Cancer Research, 23(8), 1998\u20132005. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-1371","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10247_CR147","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/S2589-7500(23)00125-5","volume":"5","author":"J He","year":"2023","unstructured":"He, J., Wang, B., Tao, J., Liu, Q., Peng, M., Xiong, S., et al. (2023). Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: A model development and external validation study. The Lancet Digital Health, 5(10), e647\u2013e656.","journal-title":"The Lancet Digital Health"},{"issue":"1","key":"10247_CR148","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12885-021-08002-4","volume":"21","author":"W Xing","year":"2021","unstructured":"Xing, W., Sun, H., Yan, C., Zhao, C., Wang, D., Li, M., et al. (2021). A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules. BMC Cancer, 21(1), 263. https:\/\/doi.org\/10.1186\/s12885-021-08002-4","journal-title":"BMC Cancer"},{"issue":"1","key":"10247_CR149","doi-asserted-by":"publisher","first-page":"16782","DOI":"10.1038\/s41598-021-96242-6","volume":"11","author":"B Wei","year":"2021","unstructured":"Wei, B., Wu, F., Xing, W., Sun, H., Yan, C., Zhao, C., et al. (2021). A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer. Scientific Reports, 11(1), 16782. https:\/\/doi.org\/10.1038\/s41598-021-96242-6","journal-title":"Scientific Reports"},{"issue":"1","key":"10247_CR150","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13148-020-00828-2","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen, C., Huang, X., Yin, W., Peng, M., Wu, F., Wu, X., et al. (2020). Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: A study in Chinese patients with very small nodules. Clinical Epigenetics, 12(1), 39. https:\/\/doi.org\/10.1186\/s13148-020-00828-2","journal-title":"Clinical Epigenetics"},{"issue":"1","key":"10247_CR151","doi-asserted-by":"publisher","first-page":"107327482096970","DOI":"10.1177\/1073274820969703","volume":"27","author":"W Huang","year":"2020","unstructured":"Huang, W., Huang, H., Zhang, S., Wang, X., Ouyang, J., Lin, Z., et al. (2020). A novel diagnosis method based on methylation analysis of SHOX2 and serum biomarker for early stage lung cancer. Cancer Control, 27(1), 1073274820969703. https:\/\/doi.org\/10.1177\/1073274820969703","journal-title":"Cancer Control"},{"issue":"7","key":"10247_CR152","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.7150\/thno.28119","volume":"9","author":"W Liang","year":"2019","unstructured":"Liang, W., Zhao, Y., Huang, W., Gao, Y., Xu, W., Tao, J., et al. (2019). Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA). Theranostics, 9(7), 2056\u20132070. https:\/\/doi.org\/10.7150\/thno.28119","journal-title":"Theranostics"},{"issue":"11","key":"10247_CR153","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","volume":"7","author":"E Schuster","year":"2021","unstructured":"Schuster, E., Taftaf, R., Reduzzi, C., Albert, M. K., Romero-Calvo, I., & Liu, H. (2021). Better together: Circulating tumor cell clustering in metastatic cancer. Trends in cancer, 7(11), 1020\u20131032.","journal-title":"Trends in cancer"},{"key":"10247_CR154","doi-asserted-by":"publisher","unstructured":"Zhang, X., Weeramange, C. E., Hughes, B. G. M., Vasani, S., Liu, Z. Y., Warkiani, M.,Hartel, G., Ladwa, R., Thiery, J. P., Kenny, L., Breik, O., & Punyadeera, C.\u00a0(2023). Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients. Cellular and Molecular Life Sciences, 81(1), 1\u201314. https:\/\/doi.org\/10.1007\/s00018-024-05269-1","DOI":"10.1007\/s00018-024-05269-1"},{"issue":"3","key":"10247_CR155","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/cancers11030380","volume":"11","author":"A Kulasinghe","year":"2019","unstructured":"Kulasinghe, A., Kapeleris, J., Cooper, C., Warkiani, M. E., O\u2019Byrne, K., & Punyadeera, C. (2019). Phenotypic characterization of circulating lung cancer cells for clinically actionable targets. Cancers, 11(3), 380.","journal-title":"Cancers"},{"issue":"5","key":"10247_CR156","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.21037\/tlcr-20-521","volume":"9","author":"J Kapeleris","year":"2020","unstructured":"Kapeleris, J., Kulasinghe, A., Warkiani, M. E., Oleary, C., Vela, I., Leo, P., et al. (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer Research, 9(5), 1795.","journal-title":"Translational Lung Cancer Research"},{"key":"10247_CR157","doi-asserted-by":"publisher","unstructured":"Kapeleris, J., Ebrahimi Warkiani, M., Kulasinghe, A., Vela, I., Kenny, L., Ladwa, R. et al. (2022). Clinical applications of circulating tumour cells and circulating tumour\u00a0DNA in non-small cell lung\u00a0cancer\u2014an update. [Review]. Frontiers in Oncology, 12. https:\/\/doi.org\/10.3389\/fonc.2022.859152","DOI":"10.3389\/fonc.2022.859152"},{"key":"10247_CR158","doi-asserted-by":"publisher","unstructured":"Kapeleris, J., Bark, J. M., Ranjit, S., Irwin, D., Hartel, G., Warkiani, M. E.,\u00a0Leo, P., O'Leary, C., Ladwa, R., O'Byrne, K., Hughes, B. G. M., & Punyadeera, C.\u00a0(2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8(7),\u00a0e09971. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09971","DOI":"10.1016\/j.heliyon.2022.e09971"},{"issue":"16_Supplement","key":"10247_CR159","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1158\/1538-7445.AM2020-3384","volume":"80","author":"A Kulasinghe","year":"2020","unstructured":"Kulasinghe, A., Kapeleris, J., Kenny, L., Hughes, B., Warkiani, M., Vela, I., et al. (2020). Characterization of the tumor microenvironment and liquid biopsy in head and neck and non-small cell lung cancer. Cancer Research, 80(16_Supplement), 3384\u20133384.","journal-title":"Cancer Research"},{"issue":"6","key":"10247_CR160","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/cells9061465","volume":"9","author":"A Kulasinghe","year":"2020","unstructured":"Kulasinghe, A., Lim, Y., Kapeleris, J., Warkiani, M., O\u2019Byrne, K., & Punyadeera, C. (2020). The use of three-dimensional DNA fluorescent in situ hybridization (3D DNA FISH) for the detection of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) circulating tumor cells. Cells, 9(6), 1465.","journal-title":"Cells"},{"issue":"9","key":"10247_CR161","doi-asserted-by":"publisher","first-page":"111298","DOI":"10.1016\/j.celrep.2022.111298","volume":"40","author":"T Pereira-Veiga","year":"2022","unstructured":"Pereira-Veiga, T., Schneegans, S., Pantel, K., & Wikman, H. (2022). Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Reports, 40(9), 111298. https:\/\/doi.org\/10.1016\/j.celrep.2022.111298","journal-title":"Cell Reports"},{"issue":"1","key":"10247_CR162","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam, M., Kato, S., & Kurzrock, R. (2022). Liquid biopsy: Current technology and clinical applications. Journal of Hematology & Oncology, 15(1), 131. https:\/\/doi.org\/10.1186\/s13045-022-01351-y","journal-title":"Journal of Hematology & Oncology"},{"issue":"2","key":"10247_CR163","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41551-018-0190-5","volume":"2","author":"M Poudineh","year":"2018","unstructured":"Poudineh, M., Sargent, E. H., Pantel, K., & Kelley, S. O. (2018). Profiling circulating tumour cells and other biomarkers of invasive cancers. Nature Biomedical Engineering, 2(2), 72\u201384. https:\/\/doi.org\/10.1038\/s41551-018-0190-5","journal-title":"Nature Biomedical Engineering"},{"issue":"23","key":"10247_CR164","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1111\/1759-7714.14702","volume":"13","author":"G Ma","year":"2022","unstructured":"Ma, G., Yang, D., Li, Y., Li, M., Li, J., Fu, J., et al. (2022). Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules. Thorac Cancer, 13(23), 3393\u20133401. https:\/\/doi.org\/10.1111\/1759-7714.14702","journal-title":"Thorac Cancer"},{"issue":"1","key":"10247_CR165","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12885-020-6524-1","volume":"20","author":"J Zheng","year":"2020","unstructured":"Zheng, J., Ye, X., Liu, Y., Zhao, Y., He, M., & Xiao, H. (2020). The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer. BMC Cancer, 20(1), 106. https:\/\/doi.org\/10.1186\/s12885-020-6524-1","journal-title":"BMC Cancer"},{"issue":"7","key":"10247_CR166","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.4103\/jcrt.JCRT_905_17","volume":"14","author":"Y Xue","year":"2018","unstructured":"Xue, Y., Cong, W., Xie, S., Shu, J., Feng, G., & Gao, H. (2018). Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules. Journal of Cancer Research and Therapeutics, 14(7), 1620\u20131626. https:\/\/doi.org\/10.4103\/jcrt.JCRT_905_17","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"10247_CR167","doi-asserted-by":"publisher","first-page":"e2100378","DOI":"10.1200\/po.21.00378","volume":"6","author":"Y Manjunath","year":"2022","unstructured":"Manjunath, Y., Suvilesh, K. N., Mitchem, J. B., Patino, D. M. A., Kimchi, E. T., Staveley-O\u2019Carroll, K. F., et al. (2022). Circulating tumor-macrophage fusion cells and circulating tumor cells complement non\u2013small-cell lung cancer screening in patients with suspicious lung-RADS 4 nodules. JCO Precision Oncology, 6, e2100378. https:\/\/doi.org\/10.1200\/po.21.00378","journal-title":"JCO Precision Oncology"},{"key":"10247_CR168","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.lungcan.2019.06.016","volume":"134","author":"Y Manjunath","year":"2019","unstructured":"Manjunath, Y., Upparahalli, S. V., Suvilesh, K. N., Avella, D. M., Kimchi, E. T., Staveley-O\u2019Carroll, K. F., et al. (2019). Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer. Lung Cancer, 134, 147\u2013150. https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.016","journal-title":"Lung Cancer"},{"issue":"1","key":"10247_CR169","doi-asserted-by":"publisher","first-page":"158","DOI":"10.21037\/jtd-21-1975","volume":"14","author":"X Lv","year":"2022","unstructured":"Lv, X., Wu, S., Xu, X., Wu, L., Chang, N., Zhang, J., et al. (2022). The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer. Journal of Thoracic Disease, 14(1), 158\u2013168. https:\/\/doi.org\/10.21037\/jtd-21-1975","journal-title":"Journal of Thoracic Disease"},{"key":"10247_CR170","doi-asserted-by":"publisher","unstructured":"Anitha, K., Posinasetty, B., Kumari, K. N., Chenchula, S., Padmavathi, R., Prakash, S., Radhika, C. (2023). Liquid biopsy for precision diagnostics and therapeutics. Clinica Chimica Acta, 554, 117746. https:\/\/doi.org\/10.1016\/j.cca.2023.117746","DOI":"10.1016\/j.cca.2023.117746"},{"key":"10247_CR171","doi-asserted-by":"publisher","first-page":"153303382110414","DOI":"10.1177\/15330338211041465","volume":"20","author":"M Zhong","year":"2021","unstructured":"Zhong, M., Zhang, Y., Pan, Z., Wang, W., Zhang, Y., Weng, Y., et al. (2021). Clinical utility of circulating tumor cells in the early detection of lung cancer in patients with a solitary pulmonary nodule. Technology in Cancer Research & Treatment, 20, 15330338211041464. https:\/\/doi.org\/10.1177\/15330338211041465","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"5","key":"10247_CR172","doi-asserted-by":"publisher","first-page":"101052","DOI":"10.1016\/j.tranon.2021.101052","volume":"14","author":"C Liu","year":"2021","unstructured":"Liu, C., Chen, H., Sun, T., Wang, H., Chen, B., & Wang, X. (2021). The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules. Translational Oncology, 14(5), 101052. https:\/\/doi.org\/10.1016\/j.tranon.2021.101052","journal-title":"Translational Oncology"},{"issue":"8","key":"10247_CR173","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/cncy.22278","volume":"128","author":"RL Katz","year":"2020","unstructured":"Katz, R. L., Zaidi, T. M., Pujara, D., Shanbhag, N. D., Truong, D., Patil, S., et al. (2020). Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathology, 128(8), 553\u2013562. https:\/\/doi.org\/10.1002\/cncy.22278","journal-title":"Cancer Cytopathology"},{"issue":"7","key":"10247_CR174","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s2213-2600(20)30081-3","volume":"8","author":"CH Marquette","year":"2020","unstructured":"Marquette, C. H., Boutros, J., Benzaquen, J., Ferreira, M., Pastre, J., Pison, C., et al. (2020). Circulating tumour cells as a potential biomarker for lung cancer screening: A prospective cohort study. The Lancet Respiratory Medicine, 8(7), 709\u2013716. https:\/\/doi.org\/10.1016\/s2213-2600(20)30081-3","journal-title":"The Lancet Respiratory Medicine"},{"issue":"25","key":"10247_CR175","doi-asserted-by":"publisher","first-page":"e2001695","DOI":"10.1002\/smll.202001695","volume":"16","author":"W Yin","year":"2020","unstructured":"Yin, W., Zhu, J., Ma, B., Jiang, G., Zhu, Y., He, W., et al. (2020). Overcoming obstacles in pathological diagnosis of pulmonary nodules through circulating tumor cell enrichment. Small (Weinheim an der Bergstrasse, Germany), 16(25), e2001695. https:\/\/doi.org\/10.1002\/smll.202001695","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"8","key":"10247_CR176","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1002\/cam4.2286","volume":"8","author":"Y Li","year":"2019","unstructured":"Li, Y., Tian, X., Gao, L., Jiang, X., Fu, R., Zhang, T., et al. (2019). Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer. Cancer Medicine, 8(8), 3782\u20133792. https:\/\/doi.org\/10.1002\/cam4.2286","journal-title":"Cancer Medicine"},{"key":"10247_CR177","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ebiom.2019.02.028","volume":"41","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q., Geng, Q., Wang, L., Huang, J., Liao, M., Li, Y., et al. (2019). Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness. eBioMedicine, 41, 236\u2013243. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.028","journal-title":"eBioMedicine"},{"issue":"1","key":"10247_CR178","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.1038\/s41598-017-09284-0","volume":"7","author":"Y He","year":"2017","unstructured":"He, Y., Shi, J., Shi, G., Xu, X., Liu, Q., Liu, C., et al. (2017). Using the new cell collector to capture circulating tumor cells from blood in different groups of pulmonary disease: A cohort study. Scientific Reports, 7(1), 9542. https:\/\/doi.org\/10.1038\/s41598-017-09284-0","journal-title":"Scientific Reports"},{"issue":"12","key":"10247_CR179","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.7150\/jca.18418","volume":"8","author":"M Mascalchi","year":"2017","unstructured":"Mascalchi, M., Maddau, C., Sali, L., Bertelli, E., Salvianti, F., Zuccherelli, S., et al. (2017). Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions. Journal of Cancer, 8(12), 2223\u20132230. https:\/\/doi.org\/10.7150\/jca.18418","journal-title":"Journal of Cancer"},{"key":"10247_CR180","doi-asserted-by":"publisher","unstructured":"Zhang, W., Duan, X., Zhang, Z., Yang, Z., Zhao, C., Liang, C. et al. (2021). Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules. JCI Insight, 6(11), https:\/\/doi.org\/10.1172\/jci.insight.148182","DOI":"10.1172\/jci.insight.148182"},{"key":"10247_CR181","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-030-44594-2_6","volume-title":"Multimodal Optical Diagnostics of Cancer,","author":"YV Kistenev","year":"2020","unstructured":"Kistenev, Y. V., Borisov, A. V., & Vrazhnov, D. A. (2020). Breathomics for lung cancer diagnosis. In V. V. Tuchin, J. Popp, & V. Zakharov (Eds.), Multimodal Optical Diagnostics of Cancer,  (pp. 209\u2013243). Cham: Springer International Publishing."},{"issue":"8","key":"10247_CR182","first-page":"e028448","volume":"9","author":"W Li","year":"2019","unstructured":"Li, W., Dai, W., Liu, M., Long, Y., Wang, C., Xie, S., et al. (2019). VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: Research protocol for an exploratory study. British Medical Journal Open, 9(8), e028448.","journal-title":"British Medical Journal Open"},{"issue":"4","key":"10247_CR183","doi-asserted-by":"publisher","first-page":"046013","DOI":"10.1088\/1752-7163\/abb18a","volume":"14","author":"D Fielding","year":"2020","unstructured":"Fielding, D., Hartel, G., Pass, D., Davis, M., Brown, M., Dent, A., et al. (2020). Volatile organic compound breath testing detects in-situ squamous cell carcinoma of bronchial and laryngeal regions and shows distinct profiles of each tumour. Journal of Breath Research, 14(4), 046013.","journal-title":"Journal of Breath Research"},{"issue":"4","key":"10247_CR184","doi-asserted-by":"publisher","first-page":"044002","DOI":"10.1088\/1752-7163\/ab2f9f","volume":"13","author":"A Campanella","year":"2019","unstructured":"Campanella, A., De Summa, S., & Tommasi, S. (2019). Exhaled breath condensate biomarkers for lung cancer. Journal of Breath Research, 13(4), 044002.","journal-title":"Journal of Breath Research"},{"issue":"1","key":"10247_CR185","doi-asserted-by":"publisher","first-page":"e182815","DOI":"10.1001\/jamaoncol.2018.2815","volume":"5","author":"GB Hanna","year":"2019","unstructured":"Hanna, G. B., Boshier, P. R., Markar, S. R., & Romano, A. (2019). Accuracy and methodologic challenges of volatile organic compound\u2013based exhaled breath tests for cancer diagnosis: A systematic review and meta-analysis. JAMA Oncology, 5(1), e182815\u2013e182815.","journal-title":"JAMA Oncology"},{"key":"10247_CR186","doi-asserted-by":"publisher","unstructured":"Janfaza, S., Khorsand, B., Nikkhah, M., & Zahiri, J. (2019). Digging deeper into volatile organic compounds associated with cancer. Biology Methods and Protocols, 4(1), https:\/\/doi.org\/10.1093\/biomethods\/bpz014","DOI":"10.1093\/biomethods\/bpz014"},{"issue":"8","key":"10247_CR187","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/bios10080084","volume":"10","author":"C Baldini","year":"2020","unstructured":"Baldini, C., Billeci, L., Sansone, F., Conte, R., Domenici, C., & Tonacci, A. (2020). Electronic nose as a novel method for diagnosing cancer: A systematic review. Biosensors, 10(8), 84.","journal-title":"Biosensors"},{"key":"10247_CR188","doi-asserted-by":"publisher","first-page":"104294","DOI":"10.1016\/j.compbiomed.2021.104294","volume":"131","author":"K Chen","year":"2021","unstructured":"Chen, K., Liu, L., Nie, B., Lu, B., Fu, L., He, Z., et al. (2021). Recognizing lung cancer and stages using a self-developed electronic nose system. Computers in Biology and Medicine, 131, 104294.","journal-title":"Computers in Biology and Medicine"},{"key":"10247_CR189","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12257-020-0132-4","volume":"26","author":"SW Cho","year":"2021","unstructured":"Cho, S. W., Ko, H. J., & Park, T. H. (2021). Identification of a lung cancer biomarker using a cancer cell line and screening of olfactory receptors for biomarker detection. Biotechnology and Bioprocess Engineering, 26, 55\u201362.","journal-title":"Biotechnology and Bioprocess Engineering"},{"key":"10247_CR190","doi-asserted-by":"publisher","unstructured":"Wang, P., Huang, Q., Meng, S., Mu, T., Liu, Z., He, M., Li, Q., Zhao, S., Wang, S., & Qui, M (2022). Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study. EClinicalMedicine, 47. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101384","DOI":"10.1016\/j.eclinm.2022.101384"},{"issue":"11","key":"10247_CR191","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1021\/cr300174a","volume":"112","author":"M Hakim","year":"2012","unstructured":"Hakim, M., Broza, Y. Y., Barash, O., Peled, N., Phillips, M., Amann, A., et al. (2012). Volatile organic compounds of lung cancer and possible biochemical pathways. Chemical Reviews, 112(11), 5949\u20135966.","journal-title":"Chemical Reviews"},{"issue":"11","key":"10247_CR192","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/bios10110171","volume":"10","author":"S Scarlata","year":"2020","unstructured":"Scarlata, S., Finamore, P., Meszaros, M., Dragonieri, S., & Bikov, A. (2020). The role of electronic noses in phenotyping patients with chronic obstructive pulmonary disease. Biosensors, 10(11), 171.","journal-title":"Biosensors"},{"issue":"11","key":"10247_CR193","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/cancers16111980","volume":"16","author":"E Boutsikou","year":"2024","unstructured":"Boutsikou, E., Hardavella, G., Fili, E., Bakiri, A., Gaitanakis, S., Kote, A., et al. (2024). The role of biomarkers in lung cancer screening. Cancers, 16(11), 1980.","journal-title":"Cancers"},{"issue":"6","key":"10247_CR194","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/cancers13061431","volume":"13","author":"P-H Tsou","year":"2021","unstructured":"Tsou, P.-H., Lin, Z.-L., Pan, Y.-C., Yang, H.-C., Chang, C.-J., Liang, S.-K., et al. (2021). Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer. Cancers, 13(6), 1431.","journal-title":"Cancers"},{"issue":"3","key":"10247_CR195","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/metabo9030052","volume":"9","author":"Z Jia","year":"2019","unstructured":"Jia, Z., Patra, A., Kutty, V. K., & Venkatesan, T. (2019). Critical review of volatile organic compound analysis in breath and in vitro cell culture for detection of lung cancer. Metabolites, 9(3), 52.","journal-title":"Metabolites"},{"key":"10247_CR196","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2021.02.006","volume":"154","author":"X Chen","year":"2021","unstructured":"Chen, X., Muhammad, K. G., Madeeha, C., Fu, W., Xu, L., Hu, Y., et al. (2021). Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection. Lung Cancer, 154, 197\u2013205. https:\/\/doi.org\/10.1016\/j.lungcan.2021.02.006","journal-title":"Lung Cancer"},{"issue":"3","key":"10247_CR197","doi-asserted-by":"publisher","first-page":"036013","DOI":"10.1088\/1752-7163\/ab21aa","volume":"13","author":"M Phillips","year":"2019","unstructured":"Phillips, M., Bauer, T. L., & Pass, H. I. (2019). A volatile biomarker in breath predicts lung cancer and pulmonary nodules. Journal of Breath Research, 13(3), 036013. https:\/\/doi.org\/10.1088\/1752-7163\/ab21aa","journal-title":"Journal of Breath Research"},{"issue":"10","key":"10247_CR198","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.jtho.2017.06.073","volume":"12","author":"D Shlomi","year":"2017","unstructured":"Shlomi, D., Abud, M., Liran, O., Bar, J., Gai-Mor, N., Ilouze, M., et al. (2017). Detection of lung cancer and EGFR mutation by electronic nose system. Journal of Thoracic Oncology, 12(10), 1544\u20131551. https:\/\/doi.org\/10.1016\/j.jtho.2017.06.073","journal-title":"Journal of Thoracic Oncology"},{"issue":"13","key":"10247_CR199","doi-asserted-by":"publisher","first-page":"2100104","DOI":"10.1002\/advs.202100104","volume":"8","author":"QX Liu","year":"2021","unstructured":"Liu, Q. X., Zhou, D., Han, T. C., Lu, X., Hou, B., Li, M. Y., et al. (2021). A noninvasive multianalytical approach for lung cancer diagnosis of patients with pulmonary nodules. Advanced Science, 8(13), 2100104.","journal-title":"Advanced Science"},{"key":"10247_CR200","doi-asserted-by":"publisher","first-page":"853801","DOI":"10.3389\/fonc.2022.853801","volume":"12","author":"M Ye","year":"2022","unstructured":"Ye, M., Tong, L., Zheng, X., Wang, H., Zhou, H., Zhu, X., et al. (2022). A classifier for improving early lung cancer diagnosis incorporating artificial intelligence and liquid biopsy. Frontiers in Oncology, 12, 853801. https:\/\/doi.org\/10.3389\/fonc.2022.853801","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"10247_CR201","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.21037\/tlcr-21-896","volume":"10","author":"J Shi","year":"2021","unstructured":"Shi, J., Li, F., Yang, F., Dong, Z., Jiang, Y., Nachira, D., et al. (2021). The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma. Transl Lung Cancer Res, 10(11), 4266\u20134280. https:\/\/doi.org\/10.21037\/tlcr-21-896","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10247_CR202","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1038\/s41598-021-83907-5","volume":"11","author":"A Shaffie","year":"2021","unstructured":"Shaffie, A., Soliman, A., Fu, X. A., Nantz, M., Giridharan, G., van Berkel, V., et al. (2021). A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer. Scientific Reports, 11(1), 4597. https:\/\/doi.org\/10.1038\/s41598-021-83907-5","journal-title":"Scientific Reports"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10247-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:36:49Z","timestamp":1743464209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":202,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10247"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10247-5","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients consent statement"}},{"value":"None of the figures were taken from other people\u2019s work. The figures were prepared using BioRender software.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}